Effect of MAO-B Inhibitors on Neurometabolic Profile of Patients Affected by Parkinson Disease: A Proton Magnetic Resonance Spectroscopy Study

Effect of MAO-B Inhibitors on Neurometabolic Profile of Patients Affected by Parkinson Disease: A Proton Magnetic Resonance Spectroscopy Study

Parkinson’s Disease (PD) is the most common neurodegenerative movement disorder whose treatment is symptomatic. No suitable methods for assessing the effects of dopaminergic drugs on disease progression in clinical trials have yet been provided. The aim of this longitudinal study is to evaluate the...

Full description

Bibliographic Details
Main Authors: Lilla Bonanno, Rosella Ciurleo, Silvia Marino, Claudio Ruvolo, Rosa Morabito, Alessia Bramanti, Francesco Corallo
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Journal of Clinical Medicine
Subjects:
cerebral cortex
choline
disease progression
MAO-B inhibitors
N-acetylaspartate
neurometabolites
Online Access:https://www.mdpi.com/2077-0383/11/7/1931

Internet

https://www.mdpi.com/2077-0383/11/7/1931

Similar Items